Abstract
Hepatitis C is the most common cause of chronic liver disease in the United States. The prevalence of HCV infection is higher in African Americans and Hispanics than among non-Hispanic whites. African Americans not only have a high prevalence of HCV but they also show lower response rates to treatment with pegylated interferon and Ribavirin. Studies have shown that HCV patients often have low levels of knowledge about the disease, including knowledge about modes of transmission and available treatment options. This study was based in two inner-city hospitals in Brooklyn, New York, Kings County Medical Center and The University Hospital of Brooklyn. The goal of this study was to evaluate the change in knowledge of patients with HCV and their willingness to accept treatment after a single session of on-site education which was delivered as part of a clinic visit. Our patients were from minority ethnic groups, with the majority being African Americans. There was a substantially low knowledge among patients with HCV about the etiologic agent being a virus amongst the twenty five patients who completed the study. After the educational intervention there was an increase in knowledge about risk factors for transmitting HCV, such as unprotected sexual intercourse (100% vs. 88% at baseline), tattooing and body piercing (88% vs. 64% at baseline), and sharing personal items like razors. Knowledge of the risk of developing liver cancer in patients with HCV also increased substantially (96% vs. 77% at baseline). There was a marked increase in the expressed willingness to accept treatment (88% vs. 41% baseline). The results of the educational intervention were very encouraging. These results have implication in setting up a structured educational intervention in liver clinics for HCV patients.
Similar content being viewed by others
References
Armstrong GL et al Prevalence of hepatitis C virus infection in the United States. 1999 through 2002. Ann Intern Med. 2006;144(10):705–714
World Health organization, Weekly epidemiological record (Accessed on May 15, 2006 at http://www.who.int/docstore/wer/pdf/1999/wer7449.pdf)
Alter M, Kruszon-Moran D, Nainan O, et al. The prevalence of hepatitis C Virus infection in United States, 1998 through 1994. N Engl J Med 1999;341:556–562
Center for Disease Control and Prevention (CDC) Recommendations for prevention and control of hepatitis C virus infection and HCV related disease. MMWR Morb Mortal Wkly Rep 1998;47:1–40. (Accessed September 18, 2005 at http://www.cdc.gov/mmwr/PDF/rr/rr4719.pdf)
Centers for Disease Control and Prevention. Summary of notifiable diseases: United States, 2001. MMWR Morb Mortal Wkly Rep. 2003; (Accessed September 24, 2005 at http:// www.cdc.gov/publications.htm)
Daniel S. Chronic hepatitis C treatment patterns in African American patients: an Update. Am J Gastroenterol. 2005;100:716–722
Bonacini M, Groshen S, Yu MC, et al. Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County. Am J Gastroenterol. 2001;96:2438–2441
Muir AJ, Bornstein JD, Killenburg PG, et al. Pegylated interferon alfa-2b and ribavirin for the treatment of chronic hepatitis C infection in African American and non-Hispanic whites: a preliminary report. Gastroenterology. 2002;122(Suppl 1):A630
Nair S, Eustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet. 2002;359:287–293
Stein M, Maskad J, Clarke J. Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment. Drug Alcohol Depend. 2001;61:211–215
Centers for Disease control and Prevention. National Hepatits C Prevention Strategy( CDC Viral hepatitis website). Summer 2001. (Accessed September 24, 2005 at http:// www.cdc.gov/ncidod/diseases/hepatitis/spotlights/c_strategy.htm)
Walley AY, White MC, Kushel MB, et al. Knowledge of and interest in hepatitis C treatment at a methadone clinic. J Subst Abuse Treat. 2005;28:181–187
Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999;6:35–47
National Digestive Diseases Information Clearinghouse (NDDIC), NIH Publication No. 03–4230 February 2003. (Accessed September 18, 2005 at http://www.digestive.niddk.nih.gov/ddiseases/pubs/chronichepc/)
Kalichman SC, Cherry J, Cain D. Nurse delivered antiretroviral treatment adherence intervention for people with low literacy skills and living with HIV/ AIDS. J Assoc Nurses AIDS Care. 2005;16: 3–15
Foldi MA, Belgeri MT, Perry HM, Gaebelein CJ. The effect of patient education in elderly men at risk for osteoporosis. Consult Pharm. 2005;20: 1032–1035.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gupta, K., Romney, D., Briggs, M. et al. Effects Of A Brief Educational Program On Knowledge And Willingness To Accept Treatment Among Patients With Hepatitis C At Inner-City Hospitals. J Community Health 32, 221–230 (2007). https://doi.org/10.1007/s10900-007-9046-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10900-007-9046-8